Cargando…
HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232785/ http://dx.doi.org/10.1016/j.jval.2022.04.1198 |
| _version_ | 1784735672439930880 |
|---|---|
| author | Rojas, P Epp, C Gozzo, L Geba, D Epstein, M Michel, S |
| author_facet | Rojas, P Epp, C Gozzo, L Geba, D Epstein, M Michel, S |
| author_sort | Rojas, P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9232785 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92327852022-06-27 HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites Rojas, P Epp, C Gozzo, L Geba, D Epstein, M Michel, S Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232785/ http://dx.doi.org/10.1016/j.jval.2022.04.1198 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Rojas, P Epp, C Gozzo, L Geba, D Epstein, M Michel, S HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites |
| title | HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites |
| title_full | HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites |
| title_fullStr | HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites |
| title_full_unstemmed | HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites |
| title_short | HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites |
| title_sort | hta66 outcomes examined in clinical trials of medicines for covid-19: a review of regulatory agencies' websites |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232785/ http://dx.doi.org/10.1016/j.jval.2022.04.1198 |
| work_keys_str_mv | AT rojasp hta66outcomesexaminedinclinicaltrialsofmedicinesforcovid19areviewofregulatoryagencieswebsites AT eppc hta66outcomesexaminedinclinicaltrialsofmedicinesforcovid19areviewofregulatoryagencieswebsites AT gozzol hta66outcomesexaminedinclinicaltrialsofmedicinesforcovid19areviewofregulatoryagencieswebsites AT gebad hta66outcomesexaminedinclinicaltrialsofmedicinesforcovid19areviewofregulatoryagencieswebsites AT epsteinm hta66outcomesexaminedinclinicaltrialsofmedicinesforcovid19areviewofregulatoryagencieswebsites AT michels hta66outcomesexaminedinclinicaltrialsofmedicinesforcovid19areviewofregulatoryagencieswebsites |